FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to anhydrous crystalline vinflunine salts of general formula (I) prepared with 1 or 2 equivalents of a pharmaceutically acceptable inorganic or organic acid. 
. In formula (I) [The acid] represents hydrobromic, lactic or fumaric acid for a group of water-soluble crystalline salts, as well as para-toluenesulphonic, benzoic, mandelic and para-hydroxybenzoic acid for a group of relatively water-insoluble crystalline salts.
EFFECT: preparing the anhydrous crystalline vinflunine salts.
8 cl, 8 ex, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTALLINE FORM OF VINFLUNINE DITARTRATE | 2006 |
|
RU2426735C2 |
| BIPHENYL DERIVATIVES AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING THEREOF | 1998 |
|
RU2193552C2 |
| VITAMIN D ANALOGS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2153491C2 |
| HEMI-SULPHATE NUCLEOTIDE SALT FOR TREATMENT OF HEPATITIS C VIRUS | 2018 |
|
RU2787616C2 |
| METHOD OF PRODUCING 3-ALKYL(ARYL)-2,2'-BITHIOPHENE-5-CARBOXYLIC ACIDS AND ESTERS THEREOF | 2011 |
|
RU2470930C1 |
| ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF | 2019 |
|
RU2717101C1 |
| DERIVATIVES OF BENZOCYCLOHEPTENE OR BENZOXEPINE, A METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS AND A PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2127268C1 |
| AZAINDAZOLE OR DIAZAINDAZOLE DERIVATIVES AS MEDICINE | 2012 |
|
RU2600976C2 |
| METHOD FOR REDUCING OF BROKEN OPYOID RECEPTOR FUNCTIONS | 1996 |
|
RU2307833C2 |
| URACYL AND THYMINE DERIVATIVES FOR TREATING HEPATITIS C | 2008 |
|
RU2543620C2 |
